Diagnostic Accuracy of (18)F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence

Prostate-specific membrane antigen (PSMA)–ligand PET/CT is performed on patients with prostate cancer to stage the disease initially or to identify sites of recurrence after definitive therapy. On the basis of clinical results, (18)F-PSMA-1007 is a promising PSMA PET tracer, but detailed histologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprute, Katharina, Kramer, Vasko, Koerber, Stefan A., Meneses, Manuel, Fernandez, Rene, Soza-Ried, Cristian, Eiber, Mathias, Weber, Wolfgang A., Rauscher, Isabel, Rahbar, Kambiz, Schaefers, Michael, Watabe, Tadashi, Uemura, Motohide, Naka, Sadahiro, Nonomura, Norio, Hatazawa, Jun, Schwab, Constantin, Schütz, Viktoria, Hohenfellner, Markus, Holland-Letz, Tim, Debus, Juergen, Kratochwil, Clemens, Amaral, Horacio, Choyke, Pete L., Haberkorn, Uwe, Sandoval, Camilo, Giesel, Frederik L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2021
Materias:
Theranostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679593/
https://www.ncbi.nlm.nih.gov/pubmed/32817141
http://dx.doi.org/10.2967/jnumed.120.246363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679593/
https://www.ncbi.nlm.nih.gov/pubmed/32817141
http://dx.doi.org/10.2967/jnumed.120.246363

Ejemplares similares